Bio-gene Technology Ltd (ASX:BGT)

22.0¢

right-arrow Created with Sketch. -0.02 (-8.33%)
MCAP $33.35M
Last trade 15.27pm 26/11/2021 20mins delayed

Latest Announcements

29/10/2021BGTBio-gene Technology Ltd
28/10/2021BGTBio-gene Technology Ltd
28/10/2021 Price SensitivePSBGTBio-gene Technology Ltd
27/10/2021BGTBio-gene Technology Ltd
27/10/2021 Price SensitivePSBGTBio-gene Technology Ltd
25/10/2021 Price SensitivePSBGTBio-gene Technology Ltd
14/10/2021 Price SensitivePSBGTBio-gene Technology Ltd
12/10/2021BGTBio-gene Technology Ltd

Company Overview

Bio-Gene Technology Limited is an Australia-based agriculture technology development company. The Company’s principal activity is to develop and commercialize insecticide products. It is focused on enabling novel insecticides to address the global problem of insecticide resistance and toxicity. Its novel platform technology is based on naturally occurring beta-triketones. The Company’s lead beta-triketone insecticide products include Flavocide and Qcide. Flavocide is a synthetically produced nature-identical compound. Testing of Flavocide has been undertaken and continues to be performed by both government research laboratories as well as by commercial collaborators. Qcide natural oil with high levels of tasmanone. The oil is extracted from the leaves of the Gympie Messmate, by utilizing a steam distillation process.

BGT in the news

Ag-tech company Bio-Gene Technology (BGT) signs an option agreement with Clarke Mosquito…
Bio-Gene Technology (BGT) executes a commercial deal with Evergreen Garden CareThe partnership…
Bio-Gene Technology (BGT) receives a new patent allowance by IP AustraliaThe patent…
Agtech development company Bio-Gene Technology (BGT) has seen positive results from a…

Search Previous Announcements